Basilea Pharmaceutica AG
- BID
56.5
- ASK
56.7
- 600 Units69 Units
- 07/21, 18:02:29 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
4.00%
Market Cap
684.36 Mil.
P/E Ratio
16.64
Dividend Yield
0.00 %
Earnings per Share
3.52 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 56.5 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 06:02:29 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 56.8 | 55.2 |
| PREV. DAY'S PRICE | 55.2 | (07/20) |
| CHANGE DAY BEFORE | +1.30 | 2.36 % |
| 52 WEEK HIGH / LOW | 65.2 (07/29) | 47.85 (11/06) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.90 | 6.74 | 3.52 | 4.34 | 3.23 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | 40.50 | 6.44 | 16.64 | 12.92 | 17.35 |
PRICE - BOOK RATIO | - | 6.19 | 5.26 | - | - |
PRICE - SALES RATIO | 2.72 | 2.75 | 3.22 | - | - |
PRICE - CASH FLOW RATIO | 30.09 | 7.70 | 12.06 | - | - |
Master Data
| WKN | A0B9GA |
| ISIN | CH0011432447 |
| SYMBOL | PK5 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Basilea Pharmaceutica |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Swiss Franc |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 12.40 Mil. |
| MARKET CAPITALISATION | 684.36 Mil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -3.16 % | 0.55 % | -10.53 % | -2.13 % | -4.00 % | - | - | -6.76 % |
| HIGH | 57.10 | 60.00 | 61.70 | 64.40 | 65.20 | - | - | 64.40 |
| LOW | 54.30 | 54.30 | 52.10 | 52.10 | 47.85 | - | - | 52.10 |
Dividende
pro Aktie
Basilea Pharmaceutica does not deliver dividend information
Company profile
Basilea Pharmaceutica AG engages in the discovery, development, and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000 and is headquartered in Allschwil, Switzerland.
Structured products for Basilea Pharmaceutica AG
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.